ArchivesMagazine - 21 Feb 2019Can expensive shares ever offer good value? The popular price-to-earnings valuation metric does not always tell the full story 21 February 2019|Talking Point Issue: 21 Feb 2019 - Page 18 < AstraZeneca shares wake up after pharma giant revives sales growth Beat the bank: how to get a better return on your cash > Issue: 21 Feb 2019 - Page 18 | Contents Next: Beat the bank: how to get a better return on your cash Previous: AstraZeneca shares wake up after pharma giant revives sales growth Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Steven Frazer Issue Contents Aequitas Why investors need to start watching the race to the White House Ask Tom ‘Should I invest my pension in cash while markets are uncertain?’ Big News BHP, Royal Bank of Scotland, Reckitt Benckiser and other news Retail sales figures return to form in January Eyes on March update as dividend doubts beset SSE Global dividends expected to grow by 5.1% in 2019 Is HSBC’s 6% yield enough compensation for disappointing results? Is the US about to deliver a growth shock? Editor's View Don't take your eye off the news flow Education Forget non-farm payrolls, you need to focus on PMIs instead Funds How the next generation of fund managers are trained Great Ideas Bigblu’s big broadband opportunity in the backwoods Personal Assets Trust could be a source of comfort in difficult times Great Ideas Update AstraZeneca shares wake up after pharma giant revives sales growth JD Sports surprises by taking 8.3% stake in Footasylum Six reasons to be excited about Cineworld’s shares Clinigen soars on potential for large earnings boost Investment Trusts HG Capital Trust set for software slowdown Pershing Square hopes quarterly dividend can put dent in discount BlackRock Throgmorton exposure to shares at nine-year low How do fund managers pay for new investments? Why are investment trusts ditching performance fees and is it a smart move? Main Feature Beat the bank: how to get a better return on your cash Talking Point Can expensive shares ever offer good value?